Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.

Acta Crystallographica. Section F, Structural Biology Communications
Alkistis N MitropoulouAnna M Davies

Abstract

Immunoglobulin E (IgE) plays a central role in the allergic response, in which cross-linking of allergen by FcεRI-bound IgE triggers mast cell and basophil degranulation and the release of inflammatory mediators. The high-affinity interaction between IgE and FcεRI is a long-standing target for therapeutic intervention in allergic disease. Omalizumab is a clinically approved anti-IgE monoclonal antibody that binds to free IgE, also with high affinity, preventing its interaction with FcεRI. All attempts to crystallize the pre-formed complex between the omalizumab Fab and the Fc region of IgE (IgE-Fc), to understand the structural basis for its mechanism of action, surprisingly failed. Instead, the Fab alone selectively crystallized in different crystal forms, but their structures revealed intermolecular Fab/Fab interactions that were clearly strong enough to disrupt the Fab/IgE-Fc complexes. Some of these interactions were common to other Fab crystal structures. Mutations were therefore designed to disrupt two recurring packing interactions observed in the omalizumab Fab crystal structures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successful crystallization and subsequent stru...Continue Reading

References

Oct 1, 1990·Biochemical Society Transactions·K G DavisD R Burton
Mar 21, 1998·Journal of Molecular Biology·L J HarrisA McPherson
Apr 8, 1998·Immunotechnology : an International Journal of Immunological Engineering·C FaberA B Edmundson
Apr 27, 2002·Acta Crystallographica. Section D, Biological Crystallography·Philip C BourneAllen B Edmundson
Jun 18, 2002·Nature Immunology·Tommy WanBrian J Sutton
May 9, 2003·Protein Engineering·Christer WingrenCarl A K Borrebaeck
Mar 9, 2005·The Journal of Allergy and Clinical Immunology·Stephen HolgateColin Reisner
Dec 22, 2005·Acta Crystallographica. Section D, Biological Crystallography·Philip Evans
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Oct 24, 2007·Nature·Søren G F RasmussenBrian K Kobilka
Feb 28, 2008·Nature Reviews. Immunology·Hannah J Gould, Brian J Sutton
Aug 30, 2008·Biochemical and Biophysical Research Communications·Lei ZhengYajun Guo
Mar 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sheng LiJianping Ding
Apr 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Serdar UysalAnthony Kossiakoff
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Aug 18, 2009·Journal of Molecular Biology·Beth A Wurzburg, Theodore S Jardetzky
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Vincent B ChenDavid C Richardson
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Alexei Vagin, Alexei Teplyakov
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Nov 3, 2010·Journal of Molecular Biology·Benjamin NorthRoland L Dunbrack
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Apr 26, 2011·Nature Structural & Molecular Biology·Mary D HoldomBrian J Sutton
Jun 9, 2011·Clinical and Experimental Immunology·L Griffin, A Lawson
May 16, 2012·Protein Engineering, Design & Selection : PEDS·Eve E WeatherillDavid P Humphreys
Jul 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Balvinder DhaliwalBrian J Sutton
Jul 21, 2012·The Journal of Biological Chemistry·Susmita BorthakurJames M McDonnell
Apr 13, 2013·Current Opinion in Structural Biology·Magdalena A Bukowska, Markus G Grütter
Jun 19, 2013·The Journal of Biological Chemistry·Daopeng YuanBalvinder Dhaliwal
Jun 26, 2013·Acta Crystallographica. Section D, Biological Crystallography·Philip R Evans, Garib N Murshudov
Jan 29, 2014·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Gordon SussmanSimon Stern
Mar 7, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Balvinder DhaliwalBrian J Sutton
Mar 19, 2014·Nature Structural & Molecular Biology·Nyssa DrinkwaterBrian J Sutton
Aug 7, 2014·The World Allergy Organization Journal·Stephen T Holgate
Apr 8, 2015·Acta Crystallographica. Section F, Structural Biology Communications·Rasmus K JensenGregers Rom Andersen
Jun 27, 2015·Scientific Reports·Jon D WrightCarmay Lim
May 20, 2016·Nature Communications·Luke F PenningtonTheodore S Jardetzky

❮ Previous
Next ❯

Methods Mentioned

BETA
PISA
PCR
Protein
chips
surface plasmon resonance

Software Mentioned

XDS
Phaser
Origin
OriginLab
xia
SCALA
Coot
CCP
MOLREP
REFMAC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Crystallographica. Section F, Structural Biology Communications
Rasmus K JensenGregers Rom Andersen
Allergology International : Official Journal of the Japanese Society of Allergology
Reiko ItoShu Hashimoto
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
G D'Amato
© 2021 Meta ULC. All rights reserved